FIELD: medicine.
SUBSTANCE: method involves mixing magnetically controllable preparation and cytostatic agent of Alkeran. The so produced mixture is introduced into solid tumors localization zone. When heating mammal body, tumor is predominantly heated.
EFFECT: enhanced effectiveness in reducing solid tumor volume without toxic manifestations occurring.
3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF EXPERIMENTAL THERMOCHEMOTHERAPY OF TUMOUR | 2005 |
|
RU2348436C2 |
| METHOD FOR INDUCTION HYPERTHERMIA IN EXPERIMENT | 2001 |
|
RU2203111C2 |
| METHOD OF FERRIMAGNETIC-THERMOCHEMOTHERAPY OF MALIGNANT TUMOURS WITH COMBINATIONS OF MAGNETOCONTROLLABLE NANOMEDICINES WITH VISUALISATION OF ONCOGENESIS, DETEMINATION OF THERAPY PREFERABLE IN REAL TIME MODE AND MONITORING OF TREATMENT RESULTS IN EXPERIMENT | 2014 |
|
RU2563369C1 |
| METHOD FOR CARRYING OUT PHOTODYNAMIC THERAPY OF SOLID EHRLICH CARCINOMA IN MICE | 2021 |
|
RU2774589C1 |
| METHOD OF SUPPRESSION OF TUMOR GROWTH | 1996 |
|
RU2114623C1 |
| MEANS TO INHIBIT TUMOR GROWTH | 1995 |
|
RU2106146C1 |
| INDUCTION HYPERTHERMIA DEVICE USABLE IN EXPERIMENT | 2001 |
|
RU2211713C2 |
| DERIVATIVE OF THE CLASS OF N-GLYCOSIDES INDOLO[2,3-A]PYRROLO[3,4-C]CARBAZOLE-5,7-DIONE - N-{12-(β-D-XYLOPYRANOSYL)-5,7-DIOXO-INDOLO[2,3-A]PYRROLO[3,4-C]CARBAZOL-6-YL} PYRIDINE-2-CARBOXAMIDE, WHICH HAS CYTOTOXIC AND ANTITUMOR ACTIVITY | 2017 |
|
RU2667906C1 |
| AGENT FOR PROPHYLAXIS DISEASES OF ONCOLOGICAL AND NON-ONCOLOGICAL PATTERN AND FOR CORRECTION OF HOMEOSTASIS DISTURBANCES | 2001 |
|
RU2208446C2 |
| TUMOUR THERAPY AGENT | 2019 |
|
RU2726801C1 |
